André J Olthaar Selected Research

Uridine Diphosphate N-Acetylgalactosamine

11/2002

Muscle uridine diphosphate-hexosamines do not decrease despite correction of hyperglycemia-induced insulin resistance in type 2 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

André J Olthaar Research Topics

Disease

3	Insulin Resistance 10/2004 - 11/2002
2	Type 2 Diabetes Mellitus (MODY) 10/2004 - 11/2002
2	Hyperglycemia 10/2004 - 11/2002
1	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 01/2022
1	Congenital Disorders of Glycosylation 04/2011
1	Galactosemias (Galactosemia) 04/2011
1	Ovarian Neoplasms (Ovarian Cancer) 05/2008
1	Ovarian Epithelial Carcinoma 05/2008
1	Hyperlipidemias (Hyperlipidemia) 10/2004

Drug/Important Bio-Agent (IBA)

3	Uridine Diphosphate (UDP)IBA 10/2004 - 11/2002
3	HexosaminesIBA 10/2004 - 11/2002
2	Insulin (Novolin)FDA Link 10/2004 - 11/2002
2	AcetylglucosamineIBA 10/2004 - 11/2002
2	Uridine Diphosphate Glucose (UDP Glucose)IBA 10/2004 - 11/2002
2	Uridine Diphosphate Galactose (UDP Galactose)IBA 10/2004 - 11/2002
2	Glucose (Dextrose)FDA LinkGeneric 02/2004 - 11/2002
1	Androstenedione (4 Androstene 3,17 dione)IBA 01/2022
1	GlucocorticoidsIBA 01/2022
1	17-alpha-Hydroxyprogesterone (17 Hydroxyprogesterone)IBA 01/2022
1	phosphomannomutaseIBA 04/2011
1	Congenital disorder of glycosylation type 1AIBA 04/2011
1	Protein Isoforms (Isoforms)IBA 04/2011
1	Monoclonal AntibodiesIBA 05/2008
1	AntibodiesIBA 05/2008
1	LeptinIBA 10/2004
1	AcetylgalactosamineIBA 10/2004
1	HexosesIBA 10/2004
1	Uridine Diphosphate N-AcetylgalactosamineIBA 11/2002

Therapy/Procedure

1	Therapeutics 05/2008